94
2
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T8719 |
SC99
|
Apoptosis; JAK; STAT | Angiogenesis; Apoptosis; Chromatin/Epigenetic; JAK/STAT signaling; Stem Cells |
SC99 是一种口服有效选择性STAT3抑制剂,靶向 JAK2-STAT3 途径,抑制血小板活化和聚集,有抗骨髓瘤和抗血栓活性。它结合在 JAK2 的 ATP 结合袋中,抑制 JAK2 和 STAT3 的磷酸化。 | |||
T6541 |
Ibutilide Fumarate
Corvert Fumarate,U70226E,富马酸伊布利特 |
Calcium Channel; Sodium Channel | Membrane transporter/Ion channel; Metabolism |
Ibutilide Fumarate (U70226E) 是一种 III 类抗心律失常药物,可作用于急性心梗阻塞。 | |||
T8491 |
Vorolanib
CM082,X-82 |
VEGFR; PDGFR | Angiogenesis; Tyrosine Kinase/Adaptors |
Vorolanib (X-82) 是一种有效的 ATP 结合盒 (ABC) 转运蛋白抑制剂,是一种有效的、具有口服活性的 VEGFR/PDGFR 抑制剂,是一种血管生成抑制剂,与 ZD1839 联用具有抗肿瘤作用。 | |||
T3148 |
MK-571 sodium
L-660711 (sodium salt),L-660711 sodium salt,Verlukast sodium,L-660711,MK571,MK-571 sodium salt,Propanoic acid |
Leukotriene Receptor; LTR | GPCR/G Protein; Immunology/Inflammation |
MK-571 sodium (L-660711 sodium salt) 是一种可口服的选择性白三烯 D4受体拮抗剂,在豚鼠和人肺膜的 Ki 分别为0.22 和 2.1 nM。 | |||
T6152 |
PD318088
|
MEK | MAPK |
PD318088 是非 ATP 竞争性的MEK1/2变构抑制剂,是 PD184352 的结构类似物。它在MEK1 活性位点与 ATP 结合位点相邻的区域与 ATP 同时结合,可用于癌症研究。 | |||
T24111 |
GSK3i XIII
GSK3 inhibitor XIII,GSK3iXIII,GSK3i-XIII |
GSK-3 | PI3K/Akt/mTOR signaling; Stem Cells |
GSK3i XIII (GSK3 inhibitor XIII) 是ATP 竞争性GSK-3抑制剂(Ki: 24 nM)。 | |||
TQ0186 |
Ko 143
|
BCRP; ABC | Membrane transporter/Ion channel |
Ko 143 有效且选择性抑制 ATP 结合盒亚家族 G 成员 2 (ABCG2/BCRP) | |||
T15385 |
Glibornuride
|
Potassium Channel | Membrane transporter/Ion channel |
Glibornuride 是对 ATP 敏感的 K+通道 (KATP 通道) 阻滞剂,pKi 为 5.75。Glibornuride 显示抗糖尿病活性。 | |||
T13547L |
AMP-PCP disodium
|
HSP | Cytoskeletal Signaling; Metabolism |
AMP-PCP disodium 是一种 ATP 类似物,具有与 Hsp90 N 末端结构域的结合亲和力,其 Kd 值为 3.8 μM。AMP-PCP disodium 的结合有助于形成 Hsp90 活性同型二聚体。 | |||
T15375 |
Inavolisib
GDC-0077,RG6114 |
Apoptosis; PI3K | Apoptosis; PI3K/Akt/mTOR signaling |
Inavolisib (GDC-0077) 是一种可口服的选择性PI3Kα抑制剂,IC50值为0.038 nM。Inavolisib 通过与 PI3K 的 ATP 结合位点结合而发挥其活性,从而抑制了 PIP2 到 PIP3 的磷酸化。 | |||
T8864 |
Thymidylate Kinase Inhibitor, YMU1
|
Others | Others |
YMU1 是一种选择性抑制剂,特异性作用于人胸苷酸激酶 (IC50: 610 nM) 。 | |||
T10585 |
Bozitinib
CBT-101,PLB-1001 |
c-Met/HGFR | Tyrosine Kinase/Adaptors |
Bozitinib (PLB-1001) 是一种可透过血脑屏障的、高效的、选择性的的、 ATP 竞争性的小分子 c-MET 激酶抑制剂,能够与酪氨酸激酶超家族的常规 ATP 结合口袋结合。 | |||
T12609 |
R-10015
|
LIM Kinase; Reverse Transcriptase | Cell Cycle/Checkpoint; Microbiology/Virology |
R-10015 是一种高效选择性 LIMK 抑制剂,通过结合 ATP 结合口袋阻断 LIMK,抑制人 LIMK1 的 IC50值为 38 nM。它还发挥广谱抗病毒作用,可用于 HIV 感染研究。 | |||
T10965 |
DBPR112
|
EGFR | Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
DBPR112 是一种口服有效的基于氟嘧啶的 EGFR 抑制剂,对 EGFRWT 和 EGFRL858R/T790M 的 IC50 分别为 15 nM 和 48 nM。DBPR112 可以占据 ATP 结合位点。DBPR112 具有显着的抗肿瘤功效。 | |||
T6337 |
RepSox
ALK5 Inhibitor II,SJN 2511,E-616452 |
ALK; TGF-beta/Smad | Angiogenesis; Stem Cells; Tyrosine Kinase/Adaptors |
RepSox (ALK5 Inhibitor II) 是一种 TGFβR-1/ALK5 的抑制剂,可以抑制 ATP 与 ALK5 结合 以及 ALK5 自磷酸化 (IC50=23/4 nM),具有选择性。RepSox 可以诱导 MEFs 细胞的脂肪生成。 | |||
T11348 |
G907
|
Antibiotic | Microbiology/Virology |
G907 是一种具有选择性和有效性的小分子ATP 结合盒 (ABC) 转运蛋白 MsbA 的拮抗剂,具有杀菌活性,可将 MsbA 捕获在朝内的脂多糖中。 G907 对大肠杆菌 MsbA 有抑制作用, IC50 值为 18 nM。 | |||
T4487 |
TNP
IP3K Inhibitor |
Others | Others |
TNP (IP3K Inhibitor) 是细胞渗透性的IP6K1和IP3K 的抑制剂, 其对IP6K1 和IP3K 的IC50值分别为 0.55 μM 和 10.2 μM。TNP 与两种酶的ATP 结合位点结合。 | |||
T7424 |
NDI-091143
|
ATP Citrate Lyase | Metabolism |
NDI-091143 是高亲和力人 ATP 柠檬酸裂解酶抑制剂,其IC50为 2.1 nM (ADP-Glo 分析),Ki 为 7.0 nM,Kd 为 2.2 nM。它能够稳定柠檬酸盐域中的大构象变化,间接抑制柠檬酸的结合和识别,进而抑制ACLY 催化变构反应。 | |||
T1849 |
Momelotinib
CYT11387,CYT387,LM-1149 |
Apoptosis; JAK; Autophagy | Angiogenesis; Apoptosis; Autophagy; Chromatin/Epigenetic; JAK/STAT signaling; Stem Cells |
Momelotinib (LM-1149) 是一种 ATP 竞争性的 JAK1/JAK2抑制剂,IC50值分别为 11 nM/18 nM。 | |||
T14366 |
AZ10606120 dihydrochloride
|
P2X Receptor | Membrane transporter/Ion channel; Neuroscience |
AZ10606120 dihydrochloride 是一种可选择的、有效的、高亲和力的受体拮抗剂,在人和大鼠 P2X 7 受体上的 K D 值分别为 1.4 和 19 nM。AZ10606120 dihydrochloride 抑制肿瘤生长,具有抗血管生成活性 。AZ 10606120在与 ATP 结合位点偶联的位点结合时充当负变构调节剂。 | |||
T16125 |
MMV390048
|
Parasite; PI4K | Microbiology/Virology; PI3K/Akt/mTOR signaling |
MMV390048 是一种抗疟药,是一种新型化学疟原虫 PI4K 抑制剂。它与疟原虫 PI4K 的 ATP 结合位点结合,不与除人类 PIP4K2C 外的其他恶性疟原虫和人类激酶结合。 | |||
T35343 |
MTI-31
MTI-31,LXI-15029 |
mTOR | PI3K/Akt/mTOR signaling |
MTI-31 (LXI-15029) 是口服有效的,高度选择性的mTORC1和mTORC2抑制剂,对 mTOR 的Kd 为 0.20 nM,IC50为 39 nM。MTI-31可用于乳腺癌的研究。 | |||
T2064 |
Semaxinib
司马沙尼,SU5416 |
VEGFR | Angiogenesis; Tyrosine Kinase/Adaptors |
Semaxinib (SU5416) 是一种选择性的 VEGFR(Flk-1/KDR) 抑制剂,其 IC50=1.23 μM。 | |||
T17182 |
TX1-85-1
|
EGFR | Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
TX1-85-1 是不可逆 Her3 抑制剂,IC50值为 23 nM。它诱导 Her3 蛋白部分降解,并减弱 Her3 依赖性信号传导。它是选择性 Her3 配体,与位于 Her3 的 ATP 结合位点的 Cys721 形成共价键。 | |||
T16550 |
PKR-IN-C16
|
Others | Others |
PKR-IN-C16 是一种特异性蛋白激酶抑制剂。它能够抑制 PKR 的自磷酸化,解除 PKR 在原代神经元细胞培养中诱导的翻译阻断。 | |||
T8333 |
Aurintricarboxylic acid
ATA,NSC-4056,NSC4056,金精三羧酸,NSC 4056 |
Apoptosis; P2X Receptor; Influenza Virus; Topoisomerase | Apoptosis; DNA Damage/DNA Repair; Membrane transporter/Ion channel; Microbiology/Virology; Neuroscience |
Aurintricarboxylic acid (NSC-4056) 是高效的αβ-亚甲基-ATP 敏感选择性P2X1Rs 和P2X3Rs 变构拮抗剂。 它是核糖核酸酶和拓扑异构酶 II 的有效抑制剂,可阻止核酸与酶结合。 | |||
T2024 |
A-803467
A 803467,A803467 |
Sodium Channel | Membrane transporter/Ion channel |
A-803467 是有效的、选择性的河豚毒素不敏感型Nav1.8 钠通道阻断剂 。它在炎症性疼痛和神经性疼痛模型中有缓解疼痛作用。它通过与 ATP-binding cassette subfamily G member 2 (ABCG2) 转运蛋白的相互作用,增强了传统抗癌物的化疗敏感性。 | |||
T1448L |
Dasatinib monohydrate
达沙替尼,BMS-354825 Monohydrate |
Apoptosis; Bcr-Abl; Src; c-Kit; Ephrin Receptor; Autophagy | Angiogenesis; Apoptosis; Autophagy; Cytoskeletal Signaling; Tyrosine Kinase/Adaptors |
Dasatinib monohydrate (BMS-354825 Monohydrate) 是一种具有口服活性的,ATP 竞争性的双重Src/Bcr-Abl 抑制剂,有抗肿瘤活性,还诱导凋亡和自噬。它抑制Src 和Bcr-Abl 的IC50分别为 0.5 nM 和 <1.0 nM,Ki 值分别为 16 pM 和 30 pM。 | |||
T23881 |
Wee1 Inhibitor II
Wee1-Inhibitor II,Wee1-Inhibitor-II,Wee1 Inhibitor-II |
||
Wee1 Inhibitor II is an ATP-binding site-targeting Wee1 inhibitor. | |||
T41113 |
3BrB-PP1
3BrB-PP1 |
||
3BrB-PP1 is an ATP-competitive analog that exhibits specific inhibitory activity towards protein kinase. It is effective in inhibiting protein kinase with mutations in the ATP-binding pocket, specifically the mutation of Thr97 within Sty1's ATP-binding pocket. | |||
T23869 |
WEE1-IN-4
Wee1-Inhibitor-I,Wee1 Inhibitor-I,Wee1 Inhibitor I,Wee1-Inhibitor I |
||
Wee1 Inhibitor I is an ATP-binding site-targeting Wee1 inhibitor. | |||
T24099 |
GP29
GP-29,GP 29 |
||
GP29 is a Type II kinase inhibitor of the IRE1α endoribonuclease that acts by targeting the ATP-binding pocket of IRE1α. | |||
T18917 |
ATP-Red 1
|
Others | Others |
ATP-Red 1 is a multisite-binding switchable fluorescent probe. It can rapidly and selectively respond to intracellular concentrations of ATP in living cells. | |||
T28389 |
PF-6422899
PF6422899,PF 6422899 |
||
PF-6422899 irreversibly inhibits EGFR kinase activity by binding covalently to active-site cysteine residues in the ATP binding pocket of EGFR. | |||
T0373L1 |
Erlotinib mesylate
CP-358774,CP-358,774,埃罗替尼甲磺酸盐,OSI-774,CP358774,OSI 774 |
||
Erlotinib is an epidermal growth factor receptor inhibitor. Erlotinib binds in a reversible fashion to the adenosine triphosphate (ATP) binding site of the receptor. | |||
T74034 | 6-Me-ATP trisodium | ||
6-Me-ATP trisodium (N6-Methyl-ATP) 是N6-修饰的ATP衍生物,展现对GSK3良好的结合亲和力,可作为GSK3β磷酸化底物肽的磷酸基团供体。 | |||
T24098 |
GP17
GP-17,GP 17 |
||
GP17 is a type II kinase inhibitor of the IRE1α endoribonuclease that acts by targeting the ATP-binding pocket of IRE1α. | |||
T32085 |
HM30181AK
HM-30181AK,HM 30181AK |
||
HM30181AK is an inhibitor of the adenosine triphosphate (ATP) binding cassette (ABC) transporter P-glycoprotein (P-gp) with adjuvant activity. | |||
T36778 |
MK2-IN-1
MK2-IN-1 (MK2 Inhibitor) |
||
MK2-IN-1 is a potent and selecitve MAPKAPK2(MK2) inhibitor(IC50=0.11 uM) with a non-ATP competitive binding mode. | |||
T16107 |
ML230
CID44640177,SID 88095709 |
CGRP Receptor | GPCR/G Protein; Neuroscience |
ML230 is a selective ATP-binding cassette (ABC) transporter ABCG2 inhibitor. It 36-fold selective for ABCG2 over ABCB1 (EC50s: 0.13 μM and 4.65 μM, respectively). | |||
T78832 |
FGFR1 inhibitor-9
|
FGFR | Angiogenesis; Tyrosine Kinase/Adaptors |
FGFR1inhibitor-9(Compound 9),一种FGFR1抑制剂(IC50为0.85 nM),可与FGFR1的ATP结合袋发生结合,并展现出抗癌活性。 | |||
T15659 | KHK-IN-1 hydrochloride | Others | Others |
KHK-IN-1 hydrochloride is a potent inhibitor of ketohexokinase (KHK) (IC50: 12 nM). In the ATP-binding region of KHK, KHK-IN-1 hydrochloride interacts with Asp-27B. | |||
T68349 |
Lck inhibitor II
|
||
Lck inhibitor II is a cell-permeable, ATP binding site-targeting, tri-substituted pyrimidine that acts as a highly potent Lck (lymphocyte specific kinase) inhibitor | |||
T13547 |
AMP-PCP
|
HSP | Cytoskeletal Signaling; Metabolism |
AMP-PCP is an ATP analog and can bind to the Hsp90 N-terminal domain (Kd: 3.8 μM). AMP-PCP binding favors the formation of the active homodimer of Hsp90. | |||
T74033 | 6-Me-ATP | ||
6-Me-ATP(N6-Methyl-ATP)为ATP的N6修饰衍生物。该化合物与GSK3β结合亲和力显著,能有效作为GSK3β催化底物肽磷酸化的磷酸基团供体。 | |||
T62089 | FWM-1 | ||
FWM-1是一种 SARS-COV-2 NSP13 解旋酶的有效抑制剂 (结合自由能:-328.6 kcal/mol)。FWM-1 对 ATP 与 SARS-COV2 解旋酶的结合显示出有效的破坏作用。 | |||
T33955 |
PF-6808472
OX-44,OX44,PF 6808472,OX 44,PF6808472 |
||
PF-6808472 is a cell permeable covalent probe suitable for click chemistry designated to measure kinase selectivity in intact cells. PF-6808472 contains sulfonyl fluoride group, which react with conserved lysine residue within kinase ATP binding site. | |||
T10172 |
5-Iodo-indirubin-3'-monoxime
|
GSK-3; CDK | Cell Cycle/Checkpoint; PI3K/Akt/mTOR signaling; Stem Cells |
5-Iodo-indirubin-3'-monoxime 是一种 GSK-3β、CDK5/P25和CDK1/cyclin B 抑制剂,IC50值分别为 9、20 和 25 nM,与 ATP 竞争性地结合酶的催化位点。 | |||
T69727 | ADA-07 | ||
ADA-07 is a TOPK inhibitor which interacts with TOPK at the ATP-binding pocket and inhibits its kinase activity, thereby suppressing SUV-induced phosphorylation of ERK1/2, p38, and JNKs, and subsequently inhibiting AP-1 activity. | |||
T13222 |
TTT-28
|
Others | Others |
TTT-28 is a thiazole-valine peptidomimetic, and is a selective ABCB1 (P-gp/MDR1) inhibitor with high efficacy and low toxicity, which reverses the ATP-binding cassette sub-family B member 1 (ABCB1)-mediated Multidrug resistance (MDR) by selectively blocki |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T20003 |
Acridone
|
Antibacterial; ABC | Membrane transporter/Ion channel; Microbiology/Virology |
Acridone 具有抗菌、抗疟、抗病毒和抗肿瘤活性。它可诱导细胞凋亡,抑制 ABCG2 蛋白,并调节激素水平。 | |||
T37714 |
Fuscin
|
||
Fuscin is a quinonoid fungal metabolite originally isolated from O. fuscum that has diverse biological activities. It inhibits binding of the ADP/ATP translocase inhibitor atractyloside to rat liver mitochondria in an ADP-dependent manner when used at a concentration of 50 μM in a radioligand binding assay. Fuscin (20 μM) reduces the glutathione content of rat liver mitochondria to 28% of controls and inhibits NADH oxidation in sonicated pigeon heart mitochondria preparations in a concentration-... |